Veli Kairisto - UTU Research Portal

Veli Kairisto

- Docent,
Faculty of Medicine (University of Turku)

velkai@utu.fi

Publications

2 of 3

Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia (2018)
- Blood
Juul-Dam K, Ommen HB, Nyvold CG, Walter C, Valerhaugen H, Kairisto V, Abrahamsson J, Alm SJ, Jahnukainen K, Lausen B, Reinhardt D, Zeller B, Von Neuhoff N, Fogelstrand L, Hasle H
(Other publication)
Syväsekvensoinnilla verisyövän täsmädiagnoosiin ja yksilöllistettyyn hoitoon (2017)
- Kliin lab
Kairisto V
(D1 Article in a professional journal)
Syväseskvenssoinnilla verisyövän täsmädiagnoosiin ja yksilöllistettyyn hoitoon (2017)
- Kliin lab
Kairisto V
(D1 Article in a professional journal)
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR (2015)
- Leukemia
White H, Deprez L, Corbisier P, Hall V, Lin F, Mazoua S, Trapmann S, Aggerholm A, Andrikovics H, Akiki S, Barbany G, Boeckx N, Bench A, Catherwood M, Cayuela JM, Chudleigh S, Clench T, Colomer D, Daraio F, Dulucq S, Farrugia J, Fletcher L, Foroni L, Ganderton R, Gerrard G, Gineikiene E, Hayette S, El Housni H, Izzo B, Jansson M, Johnels P, Jurcek T, Kairisto V, Kizilors A, Kim DW, Lange T, Lion T, Polakova KM, Martinelli G, McCarron S, Merle PA, Milner B, Mitterbauer-Hohendanner G, Nagar M, Nickless G, Nomdedeu J, Nymoen DA, Leibundgut EO, Ozbek U, Pajic T, Pfeifer H, Preudhomme C, Raudsepp K, Romeo G, Sacha T, Talmaci R, Touloumenidou T, Van der Velden VHJ, Waits P, Wang L, Wilkinson E, Wilson G, Wren D, Zadro R, Ziermann J, Zoi K, Mueller MC, Hochhaus A, Schimmel H, Cross NCP, Emons H
(A1 Refereed original research article in a scientific journal)
Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma (2014)
- Blood Cancer Journal
R Silvennoinen, T Lundan, V Kairisto, T-T Pelliniemi, M Putkonen, P Anttila, V Huotari, P Mäntymaa, S Siitonen, L Uotila, T-L Penttilä, V Juvonen, T Selander, K Remes
(A1 Refereed original research article in a scientific journal)
Interim Analysis of a Pan European Stop Tyrosine Kinase Inhibitor Trial in Chronic Myeloid Leukemia : The EURO-SKI study (2014)
- Blood
Mahon FX, Richter J, Guilhot J, Muller MC, Dietz C, Porkka K, Hjorth-Hansen H, Gruber F, Panagoitidis P, Ossenkoppele GJ, Mayer J, Almeida A, Polakova KM, Ehrencrona H, Kairisto V, Berger MG, Stromberg UO, Mustjoki S, Hochhas A, Pfirrmann M, Saussele S
(Other publication)
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients (2013)
- British Journal of Haematology
Silvennoinen R, Kairisto V, Pelliniemi TT, Putkonen M, Anttila P, Saily M, Sikio A, Opas J, Penttila K, Kuittinen T, Honkanen T, Lundan T, Juvonen V, Luukkaala T, Remes K
(B1 Non-refereed article in a scientific journal)
Establishment of the first World Health Organization international genetic reference panel for quantitation of BCR-ABL mRNA (2010)
- Blood
White HE, Matejtschuk P, Rigsby P, Gabert J, Lin F, Wang YL, Brandford S, Müller MC, Beaufils N, Beillard E, Colomer D, Dvorakova D, Ehrencrona H, Goh H-G, El Housni H, Jones D, Kairisto V et al.
(A1 Refereed original research article in a scientific journal)
ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status (2010)
- European Journal of Haematology
Hämäläinen M, Juvonen V, Häikiö S, Lakkala T, Johansson J, Pelliniemi T-T, Salmi TT, Remes K, Kairisto V
(A1 Refereed original research article in a scientific journal)
Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy (2010)
- Blood
Kreutzman A, Juvonen V, Kairisto V, Ekblom M, Stenke L, Seggewiss R, Porkka K, Mustjoki S
(A1 Refereed original research article in a scientific journal)